Skip to main content
TipRanks
Go Ultimate75% OFF

Dolby Laboratories (DLB) AI Stock Analysis

277 Followers
DLB

Dolby Laboratories

(NYSE:DLB)

Select Model
Rating:76Outperform
Price Target:$73.00▲(19.36% Upside)
Action:reiterated
Date:08/27/26

DLB scores well on financial quality (high margins, strong free cash flow, very low leverage) and a constructive earnings outlook driven by upbeat Q4/FY26 guidance and strategic traction (VDP/auto/Atmos-Vision). The score is tempered by premium valuation (P/E ~27) and technical overbought signals (RSI/Stoch), alongside acknowledged timing volatility and uneven recent revenue trends.

Positive Factors
High-margin licensing model and cash generationDolby’s proprietary technology licensing model supports exceptional gross margins and strong cash conversion. This provides funding for continued research, ecosystem expansion, dividends and repurchases while reducing reliance on external financing.
Negative Factors
Uneven revenue and profitability trendDespite high gross margins, recent revenue contraction and lower net profitability indicate that licensing timing, product mix or demand pressure can affect earnings. Sustained weakness would reduce operating leverage and challenge long-term growth consistency.

Dolby Laboratories Key Performance Indicators (KPIs)

Remaining Performance ObligationsRepresents the value of contracted revenue yet to be recognized, offering insight into future revenue streams and business stability.

$0.00$20.00M$40.00M$60.00M$80.00MMar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

RPO jumped sharply in late‑2023 and remained elevated before drifting down through early‑2026, signaling a big wave of licensing recoveries and multi‑period contracts that are now being recognized. Management’s commentary (a large Q2 recovery, expanding OEM/streaming licenses, and growing foundational patents) explains the backlog-driven upside, but the gradual decline warns bookings haven’t consistently replaced recognized revenue—investors should watch new high‑value licensing wins and minimum‑volume commitments to judge whether revenue visibility is becoming sustainably stronger or just timing‑driven.

Data provided by:The Fly

Dolby Laboratories (DLB) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%DLB-3.73%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$5.96B
Dividend Yield
2.26%
Average Volume (3M)
811.87K
Price to Earnings (P/E)
26.7
Beta (1Y)
0.68
Revenue Growth
0.55%
EPS Growth
-13.85%
Country
US
Employees
2,051
Sector
Industrials
Sector Strength
63
Industry
Software - Application

Dolby Laboratories Business Overview & Revenue Model

Company Description

Dolby Laboratories, Inc. develops pioneering audio and visual technologies designed to enhance entertainment and communication experiences across a broad spectrum of platforms. These include cinematic venues, digital television, various transmission...

How the Company Makes Money

Dolby primarily makes money by licensing its proprietary technologies and collecting royalties tied to the use of Dolby audio and imaging solutions in products and content distribution. A major revenue stream comes from licensing agreements with cons...

Dolby Laboratories Earnings Call Summary

Earnings Call Date:Jul 30, 2026(Q3-2026)|% Change Since:18.81%|Next Earnings Date:Nov 17, 2026
Earnings Call SentimentPositive

The call conveyed a broadly positive outlook driven by strong Q4 guidance (midpoint implying ~23% YoY growth), strategic momentum in high-growth initiatives (VDP, OptiView, auto, Dolby Atmos/Vision adoption), robust margins (~90% non-GAAP gross margin), healthy cash flow ($167M) and an active capital return program (buybacks and dividend +9%). Key risks include timing-dependency of some revenue (large deals and MVCs), memory cost pressure on mobile/PC that could reduce device volumes, modest declines in foundational audio/PC, and some one-time tax and restructuring impacts. Overall, the positive strategic progress and financial strength outweigh the near-term risks and timing volatility.

Positive Updates

Q3 Revenue and EPS in Guidance
Reported revenue of $305M for Q3 FY26 (within prior guidance) and non-GAAP EPS of $0.69 (just above midpoint of guidance). Licensing revenue was $282M and products & services $23M.

Negative Updates

Dependence on Timing of Large Deals and MVCs
Management acknowledged that strong Q4 guidance is driven in part by timing (large VDP deal with Meta signed early in Q4 and minimum volume commitments that are back-end loaded), creating quarter-to-quarter volatility and potential sustainability/timing risk.

Company Guidance

Management guided Q4 FY26 revenue of $362–392M (licensing $335–365M) with non‑GAAP gross margin ~90%, non‑GAAP operating expenses $195–205M and non‑GAAP EPS $1.13–1.28 (midpoint implies ~23% YoY revenue growth), citing early‑Q4 VDP deals, higher in‑car Dolby Atmos units, wearables and timing of minimum volume commitments as drivers; for FY26 they expect revenue $1.41–1.44B (licensing $1.31–1.34B), non‑GAAP operating expenses $785–795M, non‑GAAP EPS $4.25–4.40 and about a 100‑basis‑point annual non‑GAAP operating margin improvement (up from prior 50–100 bps range), with other revenue up high‑teens (auto, VDP), broadcast up mid‑single digits, mobile up mid‑single digits, CE flattish, PC down low‑single digits, and Dolby Atmos/Dolby Vision/imaging patents revenue roughly +15% YoY; Q3 actuals to date were $305M revenue ($282M licensing, $23M products & services), non‑GAAP EPS $0.69, operating cash flow ~$167M, $65M buybacks (1.2M shares), $0.36 dividend (+9% YoY), and $756M cash & investments.

Dolby Laboratories Financial Statement Overview

Summary

High-quality financial profile: exceptionally strong gross margins (~88% annual/TTM), consistently positive free cash flow (TTM FCF ~$345M), and a very conservative balance sheet with minimal leverage (debt-to-equity ~1.8% TTM). Offsetting this strength, growth has been uneven with a sharp TTM revenue decline and some margin/return moderation versus prior peaks.

Income Statement

72Positive

Balance Sheet

92Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue1.35B1.35B1.27B1.30B1.25B1.28B
Gross Profit1.19B1.19B1.13B1.15B1.11B1.15B
EBITDA372.80M378.56M399.81M345.57M318.89M450.37M
Net Income226.18M255.02M261.82M200.66M184.09M310.23M
Balance Sheet
Total Assets3.16B3.23B3.13B2.99B2.70B3.12B
Cash, Cash Equivalents and Short-Term Investments670.05M702.60M577.75M957.11M817.58M1.27B
Total Debt47.45M38.88M46.99M50.65M50.94M72.12M
Total Liabilities563.89M595.81M643.72M622.38M451.15M518.66M
Stockholders Equity2.58B2.62B2.48B2.36B2.25B2.60B
Cash Flow
Free Cash Flow344.50M430.26M297.25M336.74M259.12M393.30M
Operating Cash Flow437.60M472.20M327.25M367.08M318.58M447.75M
Investing Cash Flow-76.55M-10.59M-286.29M54.21M-295.94M-44.91M
Financing Cash Flow-376.78M-247.24M-287.81M-236.81M-610.56M-252.51M

Dolby Laboratories Technical Analysis

Technical Analysis SentimentPositive
Last Price61.16

Price Trends

50DMA60.99Positive
100DMA58.62Positive
200DMA59.01Positive

Market Momentum

MACD1.11Positive
RSI56.00Neutral
STOCH61.99Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DLB, the sentiment is Positive. The current price of 61.16 is below the 20-day moving average (MA) of 63.40, above the 50-day MA of 60.99, and above the 200-day MA of 59.01, indicating a bullish trend. The MACD of 1.11 indicates Positive momentum. The RSI at 56.00 is Neutral, neither overbought nor oversold. The STOCH value of 61.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DLB.

Dolby Laboratories Risk Analysis

Dolby Laboratories disclosed 11 risk factors in its most recent earnings report. Dolby Laboratories reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.CustomersQ3, 2025
2.Technology StandardsQ3, 2025
3.CustomersQ2, 2025

Dolby Laboratories Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DLB against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DLBDLB76Outperform$5.96B26.738.68%2.26%0.55%-13.85%
IDCCIDCC74Outperform$7.43B23.6227.05%0.99%-11.99%-36.74%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
CRNCCRNC62Neutral$358.22M-21.82-9.84%―25.84%42.54%
ADEAADEA60Neutral$1.79B15.1524.36%1.23%22.06%57.45%
XPERXPER53Neutral$296.33M-8.91-7.66%―1.15%-495.69%
SOUNSOUN50Neutral$1.70B-21.27-13.35%―50.65%79.91%

* Industrials Sector Average

Performance Comparison

-50%0%50%100%150%DLBIDCCADEACRNCSOUNXPERDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DLB and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DLBDolby Laboratories61.16-2.33-3.67%
IDCCInterdigital274.46-58.39-17.54%
ADEAAdeia Inc.14.752.5320.65%
CRNCCerence Inc7.29-0.53-6.78%
SOUNSoundHound AI, Inc Class A3.23-8.30-71.99%
XPERXperi Inc5.930.111.89%

Dolby Laboratories Corporate Events

Business Operations and StrategyExecutive/Board Changes

Dolby Laboratories Announces New CEO and Leadership Transition

Positive
Aug 27, 2026

On August 27, 2026, Dolby Laboratories announced a leadership transition in which long-time President and Chief Executive Officer Kevin Yeaman retired and technology veteran Marc Whitten was appointed President, Chief Executive Officer and a member o...

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures

Dolby Laboratories Reports Q3 Results, Boosts Share Repurchases

Neutral
Jul 30, 2026

On July 30, 2026, Dolby Laboratories reported third-quarter fiscal 2026 revenue of $305 million, down from $316 million a year earlier, with GAAP net income falling to $29 million, or $0.30 per diluted share, versus $46 million, or $0.48 per share, i...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 27, 2026